Tag Archives: Alzheimer’s Disease

Forget about Biogen/Eisai’s promising new drug for Alzheimer’s; Study says aggressive blood-pressure treatment with existing meds reduces dementia/AD risk.

The News: After decades of prominent failures, hope arose for a drug to slow the progression of Alzheimer’s disease (AD). After heightening expectations recently, Eisai Co. Ltd. (Tokyo) and Biogen… Read more »

Tiny Swedish biotech not taking back seat to US in Alzheimer’s race. How to buy it.

The News: BioArctic AB, based in Stockholm, said it has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial… Read more »

Coffee drinkers stunned as new study suggests caffeine consumption worsens Alzheimer’s symptoms. Now what?

The News: Long-term consumption of caffeine would worsen the neuropsychiatric symptoms of people with Alzheimer’s disease, according to a study on mice, published in Frontiers in Pharmacology. So far, many studies… Read more »

Heath stock take it on the chin while immuno-oncology IPOs keep a coming.

1. Medical Stock Spotlight 1) Losers far outpaced winners last week with Edge Therapeutics Inc. (Nasdaq:EDGE) nosediving 93% over the week to $1.18. Up until last week, shares of Edge Thera… Read more »

Study says physical fitness tied to 90% drop in women’s dementia risk; that’s great, but don’t overdo it, others caution.

The News: Highly fit women in midlife were nearly 90% less likely to have dementia decades later, a prospective study in Sweden found. Over 44 years of follow-up, the adjusted… Read more »

Join a clinical trial? The success rate of such trials is higher than you thought, but still awfully low overall; especially for Alzheimer’s.

The News: Instead of less than 10% of drugs reaching the market, a new study has found that almost 15% of new compounds pass clinical trial–which still suggests that it’s… Read more »